Sarissa Biomedical was formed in November 2002 as a spin-out from Warwick University. We specialise in the development and production of novel biosensors for the measurement of neuroactive chemicals. We have developed biosensors for the following analytes: ATP, Adenosine, Inosine, Hypoxanthine, Acetylcholine, Choline, Glutamate, Glucose, Lactate and D-serine Our sensors are ideal for real-time recordings in a variety of tissues in vitro and in vivo and can be used in combination with electrophysiological techniques (extracellular recording, patch clamp recording) as well as fluorescent imaging methods. More information is available on the Sarissa Biomedical website here: www.sarissa-biomedical.com Sarissa sensors have been used extensively in a number of research applications - some of the publications that feature the biosensors can be reviewed here: http://www.sarissa-biomedical.com/publications
Looking for a particular Sarissa Biomedical Limited employee's phone or email?
The Sarissa Biomedical Limited annual revenue was $2 million in 2026.
2 people are employed at Sarissa Biomedical Limited.
The NAICS codes for Sarissa Biomedical Limited are [541711, 54, 5417, 541, 54171].
The SIC codes for Sarissa Biomedical Limited are [873, 384, 87, 38].